ARQT (STOCKS)
Arcutis Biotherapeutics, Inc. Common Stock
$26.590000
-0.290000 (-1.08%)
Prev close: $26.880000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Todd Franklin Watanabe
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,255.84M
- Employees
- 342
- P/E (TTM)
- -75.01
- P/B (TTM)
- 20.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.06 | $-0.10 | +0.1619 | +158.88% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.16 | +0.0313 | +19.40% |
|
Mar 2025 (Q1)
|
$-0.20 | $-0.21 | +0.0142 | +6.63% |
|
Dec 2024 (Q4)
|
$-0.09 | $-0.26 | +0.1701 | +65.40% |
Financial Statements
| Revenues | $317.93M |
| Benefits Costs and Expenses | $356.18M |
| Cost Of Revenue | $31.91M |
| Costs And Expenses | $356.18M |
| Gross Profit | $286.02M |
| Operating Expenses | $324.26M |
| Selling, General, and Administrative Expenses | $253.18M |
| Research and Development | $71.08M |
| Operating Income/Loss | -$38.25M |
| Income/Loss From Continuing Operations After Tax | -$44.32M |
| Income/Loss From Continuing Operations Before Tax | -$38.25M |
| Income Tax Expense/Benefit | $1.02M |
| Net Income/Loss | -$44.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$44.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$44.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.34 |
| Diluted Earnings Per Share | -$0.34 |
| Basic Average Shares | 128,220,633 |
| Diluted Average Shares | 128,220,633 |
| Assets | $370.98M |
| Current Assets | $349.22M |
| Inventory | $22.42M |
| Other Current Assets | $326.81M |
| Noncurrent Assets | $21.75M |
| Fixed Assets | $1.22M |
| Intangible Assets | $15.38M |
| Other Non-current Assets | $5.16M |
| Liabilities | $212.90M |
| Current Liabilities | $99.77M |
| Accounts Payable | $5.80M |
| Wages | $18.30M |
| Other Current Liabilities | $75.67M |
| Noncurrent Liabilities | $113.13M |
| Long-term Debt | $108.50M |
| Other Non-current Liabilities | $4.64M |
| Equity | $158.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $158.07M |
| Liabilities And Equity | $370.98M |
| Net Cash Flow From Operating Activities | -$32.56M |
| Net Cash Flow From Operating Activities, Continuing | -$32.56M |
| Net Cash Flow From Investing Activities | $38.80M |
| Net Cash Flow From Investing Activities, Continuing | $38.80M |
| Net Cash Flow From Financing Activities | -$94.16M |
| Net Cash Flow From Financing Activities, Continuing | -$94.16M |
| Net Cash Flow | -$87.92M |
| Net Cash Flow, Continuing | -$87.92M |
| Comprehensive Income/Loss | -$44.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$44.92M |
| Other Comprehensive Income/Loss | -$44.92M |
| Other Comprehensive Income/Loss Attributable To Parent | -$595.00K |